Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
What should the patient tell the physician about the growth?
The patient should tell the doctor when the growth appeared, what its size was at the time of discovery compared to its present size, and where it is located. The patient should also outline any family history of breast cancer, as well as any personal history of breast problems of any kind.
How does a physician confirm the presence of a breast growth?
A physician confirms the presence of a growth by taking a medical history (and asking numerous questions), performing a clinical examination that includes palpating (feeling) the breast, and interpreting the results of a diagnostic mammogram and sometimes other imaging studies such as ultrasound or
MRI.
Ultrasound sends sound waves into the breast that "bounce" back to receiver that can record an image on a computer screen to visualize interior structures. This technique can help distinguish between a cyst and a solid growth. The physician may also order the laboratory analysis of any nipple discharge (other than milk) for the presence of cancerous cells. After confirming the presence of a suspicious growth, the physician orders a biopsy.
Is anesthesia needed for a biopsy?
For non-surgical biopsies, the patient may need no anesthesia at all or just a local anesthesia (one that numbs the suspicious area only). Sometimes, a patient receives a sedative (calming drug) with the local anesthesia.
For surgical biopsies, the patient may receive a local anesthesia (with or without a sedative) or general anesthesia (one that induces sleep). Patients requiring general anesthesia may have to fast 8 to 12 hours before undergoing a biopsy.
What about pain and complications?
Except for a minor sting from the injected anesthesia, patients usually feel no pain before or during a procedure. After a procedure, some patients may experience some soreness and pain. Usually, an over-the-counter drug is sufficient to alleviate the discomfort.
The risk of complications, such as infection and bleeding, is small for non-surgical procedures and slightly higher for surgical procedures.
Breast cancer is the most common cancer in women and the second most common cause of cancer death in women in the U.S. Symptoms include a lump in the breast or underarm area, nipple pain, change in breast size or shape, an inverted nipple, nipple discharge, and breast skin changes. Treatment may involve chemotherapy, radiation therapy, biological therapy, hormone therapy, or surgery.
Fibrocystic breast condition (sometimes called fibrocystic breast disease) is characterized by lumpiness and usually discomfort in one or both breasts. The condition is very common and benign (not malignant). Fibrocystic breast condition is the most common cause of "lumpy breasts" in women. A common symptom of fibrocystic breast condition is breast pain or discomfort. There are two types of fibrocystic breast condition, cysts and fibrosis, and Hyperplasia and atypical hyperplasia of breast cells.
Breast lumps in women can have a variety of causes such as breast inflammation, infection, injuries, cancer, and non-cancerous growths. Breast lumps in women are diagnosed with physical exam, mammogram, ultrasound, MRI, and biopsy. Treatment of breast lumps in women depend on the cause.
The breast generally refers to the chest, however, more specifically, to the mammary gland. The mammary gland is a milk producing gland comprised largely of fat. Within the mammary gland is a complex network of branching ducts. The ducts exit from sac-like structures called lobules, which can produce milk in females. The darkened area around the nipple is called the areola. Common medical concerns in regard to the breast include breast lumps, breast cysts, breast cancer, and breast infections.
Male breast cancer accounts for 1% of all breast cancers, and most cases are found in men between the ages of 60 and 70. A man's risk of developing breast cancer is one in 1,000. Signs and symptoms include a firm mass located below the nipple and skin changes around the nipple, including puckering, redness or scaling, retraction and ulceration of the nipple. Treatment depends upon staging and the health of the patient.
Inflammatory breast cancer is an accelerated form of breast cancer that is not usually detected by mammogram or ultrasound. Symptoms of inflammatory breast cancer include pain in the breast, skin change in the breast area, bruise on the breast,sudden swelling of the breast, nipple retraction or discharge, and swelling of the lymph nodes.
Lifestyle changes, a healthy antioxidant-rich diet, exercise, and weight reduction can help reduce a woman's risk of developing breast cancer. It's important to be aware of how risk factors such as family history, lifestyle factors, breast conditions, radiation therapy, and hormonal factors may influence your chances of developing breast cancer. Mammography and breast self-examinations are crucial steps in breast cancer prevention.
As breast cancer is the most diagnosed non-skin cancer in American women, it is important to know your breast cancer risk. Risk factors include age, age at menarche, age at first live birth, history of breast abnormalities, breast biopsies, race, and history or breast cancer among first-degree relatives.